{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T16:39:16Z","timestamp":1770482356279,"version":"3.49.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00417-017-3754-2","type":"journal-article","created":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T10:08:38Z","timestamp":1501150118000},"page":"2271-2276","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Long-term follow-up of conjunctival melanoma treated with topical interferon alpha-2b eye drops as adjunctive therapy following surgical resection"],"prefix":"10.1007","volume":"255","author":[{"given":"Iku","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Kase","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Ishijima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"key":"3754_CR1","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/bjo.78.4.252","volume":"78","author":"AD Paridaens","year":"1994","unstructured":"Paridaens AD, Minassian DC, McCartney AC, Hungerford JL (1994) Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol 78:252\u2013259","journal-title":"Br J Ophthalmol"},{"key":"3754_CR2","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/BF00448801","volume":"234","author":"JC Norregaard","year":"1996","unstructured":"Norregaard JC, Gerner N, Jensen OA, Prause JU (1996) Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol 234:569\u2013572","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3754_CR3","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/archopht.118.11.1497","volume":"118","author":"CL Shields","year":"2000","unstructured":"Shields CL, Shields JA, Gunduz K, Cater J, Mercado GV, Gross N, Lally B (2000) Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients. Arch Ophthalmol 118:1497\u20131507","journal-title":"Arch Ophthalmol"},{"key":"3754_CR4","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00417-005-0093-5","volume":"244","author":"H Wuestemeyer","year":"2006","unstructured":"Wuestemeyer H, Sauerwein W, Meller D, Chauvel P, Schueler A, Steuhl KP, Bornfeld N, Anastassiou G (2006) Proton radiotherapy as an alternative to exenteration in the management of extended conjunctival melanoma. Graefes Arch Clin Exp Ophthalmol 244:438\u2013446","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3754_CR5","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/bjo.77.11.751","volume":"77","author":"PT Finger","year":"1993","unstructured":"Finger PT, Milner MS, McCormick SA (1993) Topical chemotherapy for conjunctival melanoma. Br J Ophthalmol 77:751\u2013753","journal-title":"Br J Ophthalmol"},{"key":"3754_CR6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1359-6101(01)00022-3","volume":"13","author":"F Belardelli","year":"2002","unstructured":"Belardelli F, Ferrantini M, Proietti E, Kirkwood JM (2002) Interferon-alpha in tumor immunity and immunotherapy. Cytokine Growth Factor Rev 13:119\u2013134","journal-title":"Cytokine Growth Factor Rev"},{"key":"3754_CR7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1053\/sonc.2002.33078","volume":"29","author":"J Kirkwood","year":"2002","unstructured":"Kirkwood J (2002) Cancer immunotherapy: the interferon-alpha experience. Semin Oncol 29:18\u201326","journal-title":"Semin Oncol"},{"key":"3754_CR8","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4103\/0301-4738.195013","volume":"64","author":"M Singh","year":"2016","unstructured":"Singh M, Gautam N, Gupta A, Kaur M (2016) Interferon alfa-2b in the management of recurrent conjunctival papillomatosis. Indian J Ophthalmol 64:778\u2013780","journal-title":"Indian J Ophthalmol"},{"key":"3754_CR9","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0002-9394(02)01514-3","volume":"134","author":"BA Schechter","year":"2002","unstructured":"Schechter BA, Rand WJ, Velazquez GE, Williams WD, Starasoler L (2002) Treatment of conjunctival papillomata with topical interferon Alfa-2b. Am J Ophthalmol 134:268\u2013270","journal-title":"Am J Ophthalmol"},{"key":"3754_CR10","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.ophtha.2010.03.052","volume":"117","author":"CL Karp","year":"2010","unstructured":"Karp CL, Galor A, Chhabra S, Barnes SD, Alfonso EC (2010) Subconjunctival\/perilesional recombinant interferon alpha 2b for ocular surface squamous neoplasia: a 10-year review. Ophthalmology 117:2241\u20132246","journal-title":"Ophthalmology"},{"key":"3754_CR11","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3109\/09273948.2010.486687","volume":"18","author":"CL Karp","year":"2010","unstructured":"Karp CL, Galor A, Lee Y, Yoo SH (2010) Pegylated interferon alpha 2b for treatment of ocular surface squamous neoplasia: a pilot study. Ocul Immunol Inflamm 18:254\u2013260","journal-title":"Ocul Immunol Inflamm"},{"key":"3754_CR12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000450824","volume":"7","author":"H Endo","year":"2016","unstructured":"Endo H, Kase S, Suzuki Y, Kase M (2016) Coincidence of inflamed Conjunctival carcinoma in situ and primary Pterygium. Case Rep Ophthalmol 7:208\u2013212","journal-title":"Case Rep Ophthalmol"},{"key":"3754_CR13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00417-009-1189-0","volume":"248","author":"TR Herold","year":"2010","unstructured":"Herold TR, Hintschich C (2010) Interferon alpha for the treatment of melanocytic conjunctival lesions. Graefes Arch Clin Exp Ophthalmol 248:111\u2013115","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"3754_CR14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ajo.2007.08.027","volume":"145","author":"PT Finger","year":"2008","unstructured":"Finger PT, Sedeek RW, Chin KJ (2008) Topical interferon alfa in the treatment of conjunctival melanoma and primary acquired melanosis complex. Am J Ophthalmol 145:124\u2013129","journal-title":"Am J Ophthalmol"},{"key":"3754_CR15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/01676830.2015.1093509","volume":"35","author":"A Garip","year":"2016","unstructured":"Garip A, Schaumberger MM, Wolf A, Herold TR, Miller CV, Klingenstein A, Schebitz-Walter K, Hintschich CR (2016) Evaluation of a short-term topical interferon alpha-2b treatment for histologically proven melanoma and primary acquired melanosis with atypia. Orbit 35:29\u201334","journal-title":"Orbit"},{"key":"3754_CR16","first-page":"1043","volume":"115","author":"S Kase","year":"2011","unstructured":"Kase S, Ishijima K, Noda M, Ishida S (2011) Two cases of conjunctival malignant melanoma treated with topical interferon alpha-2b drop as an adjuvant therapy. Nippon Ganka Gakkai Zasshi 115:1043\u20131047","journal-title":"Nippon Ganka Gakkai Zasshi"},{"key":"3754_CR17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/08820530500351694","volume":"21","author":"AM Poothullil","year":"2006","unstructured":"Poothullil AM, Colby KA (2006) Topical medical therapies for ocular surface tumors. Semin Ophthalmol 21:161\u2013169","journal-title":"Semin Ophthalmol"},{"key":"3754_CR18","first-page":"449","volume":"39","author":"JG Crowston","year":"1998","unstructured":"Crowston JG, Akbar AN, Constable PH, Occleston NL, Daniels JT, Khaw PT (1998) Antimetabolite-induced apoptosis in Tenon\u2019s capsule fibroblasts. Invest Ophthalmol Vis Sci 39:449\u2013454","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"3754_CR19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00002341-199805000-00012","volume":"14","author":"JA Shields","year":"1998","unstructured":"Shields JA, Shields CL, De Potter P (1998) Surgical management of circumscribed conjunctival melanomas. Ophthal Plast Reconstr Surg 14:208\u2013215","journal-title":"Ophthal Plast Reconstr Surg"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-017-3754-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3754-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-017-3754-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T07:54:49Z","timestamp":1507881289000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-017-3754-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":19,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["3754"],"URL":"https:\/\/doi.org\/10.1007\/s00417-017-3754-2","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]}}}